SESN
Income statement / Annual
Last year (2024), Sesen Bio, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, Sesen Bio, Inc.'s net income was -$60.48 M.
See Sesen Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2024 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00 |
$40.00 M |
$26.54 M |
$11.24 M |
$0.00 |
$0.00 |
$425.00 K |
$29.98 M |
$990.00 K |
$2.24 M |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$40.00 M
|
$26.54 M
|
$11.24 M
|
$0.00
|
$0.00
|
$425.00 K
|
$29.98 M
|
$990.00 K
|
$2.24 M
|
| Gross Profit Ratio |
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$59.67 M
|
$38.59 M
|
$25.31 M
|
$29.19 M
|
$24.66 M
|
$14.08 M
|
$12.51 M
|
$13.48 M
|
$26.34 M
|
$26.70 M
|
| General & Administrative Expenses |
$22.14 M
|
$39.79 M
|
$29.39 M
|
$14.30 M
|
$12.21 M
|
$11.62 M
|
$8.07 M
|
$14.74 M
|
$9.85 M
|
$8.47 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$22.14 M
|
$39.79 M
|
$29.39 M
|
$14.30 M
|
$12.21 M
|
$11.62 M
|
$8.07 M
|
$14.74 M
|
$9.85 M
|
$8.47 M
|
| Other Expenses |
$0.00
|
$296.00 K
|
-$60.00 K
|
$125.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$81.81 M
|
$78.38 M
|
$54.71 M
|
$43.49 M
|
$36.87 M
|
$25.70 M
|
$20.58 M
|
$28.22 M
|
$36.19 M
|
$35.17 M
|
| Cost And Expenses |
$0.00
|
$78.38 M
|
$54.71 M
|
$43.49 M
|
$36.87 M
|
$25.70 M
|
$20.58 M
|
$28.22 M
|
$36.19 M
|
$35.17 M
|
| Interest Income |
$0.00
|
$1.85 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$247.00 K
|
$1.40 M
|
$376.00 K
|
| Depreciation & Amortization |
$0.00
|
$13.00 K
|
-$39.14 M
|
-$22.24 M
|
$219.00 K
|
$208.00 K
|
$285.00 K
|
$178.00 K
|
$366.00 K
|
$410.00 K
|
| EBITDA |
$0.00 |
-$50.84 M |
-$8.55 M |
-$21.08 M |
$34.97 M |
-$24.69 M |
-$19.64 M |
$1.22 M |
-$31.69 M |
-$32.93 M |
| EBITDA Ratio |
0
|
-1.27
|
-0.32
|
-1.88
|
0
|
0
|
-46.22
|
0.04
|
-32.01
|
-14.68
|
| Operating Income Ratio |
0
|
-0.65
|
-0.32
|
-1.88
|
0
|
0
|
-68.84
|
0.1
|
-35.55
|
-14.68
|
| Total Other Income/Expenses Net |
$0.00
|
$2.15 M
|
-$60.00 K
|
$125.00 K
|
$991.00 K
|
$807.00 K
|
$226.00 K
|
-$970.00 K
|
$3.14 M
|
-$1.23 M
|
| Income Before Tax |
-$60.48 M
|
-$23.76 M
|
-$8.61 M
|
-$20.95 M
|
-$107.50 M
|
-$33.69 M
|
-$29.03 M
|
$1.90 M
|
-$33.45 M
|
-$34.16 M
|
| Income Before Tax Ratio |
0
|
-0.59
|
-0.32
|
-1.86
|
0
|
0
|
-68.3
|
0.06
|
-33.79
|
-15.23
|
| Income Tax Expense |
$0.00
|
-$3.88 M
|
-$8.27 M
|
$1.45 M
|
$71.62 M
|
$807.00 K
|
$226.00 K
|
$5.00 K
|
$4.53 M
|
$0.00
|
| Net Income |
-$60.48 M
|
-$19.88 M
|
-$336.00 K
|
-$22.40 M
|
-$179.12 M
|
-$34.50 M
|
-$29.03 M
|
$1.89 M
|
-$33.45 M
|
-$34.16 M
|
| Net Income Ratio |
0
|
-0.5
|
-0.01
|
-1.99
|
0
|
0
|
-68.3
|
0.06
|
-33.79
|
-15.23
|
| EPS |
-1.46 |
-1.99 |
-0.0369 |
-3.79 |
-39.4 |
-11.17 |
-22.24 |
1.8 |
-35.2 |
-47.4 |
| EPS Diluted |
-1.46 |
-1.99 |
-0.0369 |
-3.8 |
-39.4 |
-11.17 |
-22.24 |
1.8 |
-35.2 |
-47.4 |
| Weighted Average Shares Out |
$41.46 M
|
$9.97 M
|
$9.12 M
|
$5.91 M
|
$4.55 M
|
$3.09 M
|
$1.31 M
|
$1.05 M
|
$949.65 K
|
$732.20 K
|
| Weighted Average Shares Out Diluted |
$41.46 M
|
$9.97 M
|
$9.12 M
|
$5.91 M
|
$4.55 M
|
$3.09 M
|
$1.31 M
|
$1.09 M
|
$949.65 K
|
$732.20 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
